Skip to main content
Top
Published in: Infection 4/2019

01-08-2019 | Oral and Maxillofacial Surgery | Review

A systematic review of latest evidence for antibiotic prophylaxis and therapy in oral and maxillofacial surgery

Authors: Sebastian Blatt, Bilal Al-Nawas

Published in: Infection | Issue 4/2019

Login to get access

Abstract

Purpose

Especially in oral and maxillofacial surgery, where procedures involving the aero-digestive tract considered clean contaminated, surgical site infections (SSI) represent a severe health care burden. To improve implementation and methodological standard, an upgrade of the existing S1 guideline to a consensus-guided S3 guideline was initiated by the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V., AWMF, register number 067/009) and 25 collaborating medical societies.

Methods

A systematic literature search based on the Scottish Intercollegiate GL Network (SIGN)-search string for the guideline “Antibiotic prophylaxis in surgery” from 2014 was performed and equivalent exclusion/inclusion criteria were applied. An additional hand search provided latest evidence.

Results

In total, 80 clinical trials, retrospective studies, reviews, and meta-analysis were analyzed. For orthognathic surgery, prolonged antibiotic regimen may reduce risk for SSI but there is lack of evidence for the effects of short- vs. long-term therapy. For maxillofacial traumatology, antibiotic prophylaxis might reduce SSI but prolonged postoperative dosing shows no benefit. For clean-contaminated oncological interventions, anti-infectious therapy for 24 h only can reduce SSI; patients may not benefit from prolonged regimen. In contrast, for dentoalveolar procedures such as implantology or third molar removal, literature reveals ambivalent results.

Conclusion

In summary, consensus process of the planned S3 guideline is much in need to transfer the indecisive results for antibiotic prophylaxis in dentoalveolar surgery in clinical praxis and encourage adherence to guidelines.
Literature
4.
go back to reference SIGN SIGN. Antibiotic prophylaxis in surgery. (SIGN publication no104) 2014; 2008. SIGN SIGN. Antibiotic prophylaxis in surgery. (SIGN publication no104) 2014; 2008.
9.
go back to reference Higgins JPT GS. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. In: The Cochrane Collaboration; 2011. Accessed 13 Mar 2017. Higgins JPT GS. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. In: The Cochrane Collaboration; 2011. Accessed 13 Mar 2017.
20.
23.
25.
go back to reference Campos GB, Lucena EE, da Silva JS, Gomes PP, Germano AR. Efficacy assessment of two antibiotic prophylaxis regimens in oral and maxillofacial trauma surgery: preliminary results. Int J Clin Exp Med. 2015;8:2846–52.PubMedPubMedCentral Campos GB, Lucena EE, da Silva JS, Gomes PP, Germano AR. Efficacy assessment of two antibiotic prophylaxis regimens in oral and maxillofacial trauma surgery: preliminary results. Int J Clin Exp Med. 2015;8:2846–52.PubMedPubMedCentral
49.
go back to reference Iglesias-Martin F, Garcia-Perla-Garcia A, Yanez-Vico R, Aced-Jimenez E, Arjona-Gerveno E, Gonzalez-Padilla JD, et al. Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars. Med Oral Patologia Oral y Cirugia Bucal. 2014;19:e612–5.CrossRef Iglesias-Martin F, Garcia-Perla-Garcia A, Yanez-Vico R, Aced-Jimenez E, Arjona-Gerveno E, Gonzalez-Padilla JD, et al. Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars. Med Oral Patologia Oral y Cirugia Bucal. 2014;19:e612–5.CrossRef
51.
go back to reference Bezerra TP, Studart-Soares EC, Scaparo HC, Pita-Neto IC, Batista SH, Fonteles CS. Prophylaxis versus placebo treatment for infective and inflammatory complications of surgical third molar removal: a split-mouth, double-blind, controlled, clinical trial with amoxicillin (500 mg). J Oral Maxillofac Surg. 2011;69:e333–9. https://doi.org/10.1016/j.joms.2011.03.055.CrossRefPubMed Bezerra TP, Studart-Soares EC, Scaparo HC, Pita-Neto IC, Batista SH, Fonteles CS. Prophylaxis versus placebo treatment for infective and inflammatory complications of surgical third molar removal: a split-mouth, double-blind, controlled, clinical trial with amoxicillin (500 mg). J Oral Maxillofac Surg. 2011;69:e333–9. https://​doi.​org/​10.​1016/​j.​joms.​2011.​03.​055.CrossRefPubMed
64.
go back to reference Arteagoitia MI, Barbier L, Santamaria J, Santamaria G, Ramos E. Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysis. Medicina Oral Patología Oral y Cirugia Bucal. 2016. https://doi.org/10.4317/medoral.21139.CrossRef Arteagoitia MI, Barbier L, Santamaria J, Santamaria G, Ramos E. Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysis. Medicina Oral Patología Oral y Cirugia Bucal. 2016. https://​doi.​org/​10.​4317/​medoral.​21139.CrossRef
73.
77.
go back to reference Arduino PG, Tirone F, Schiorlin E, Esposito M. Single preoperative dose of prophylactic amoxicillin versus a 2-day postoperative course in dental implant surgery: a two-centre randomised controlled trial. Eur J Oral Implantol. 2015;8:143–9.PubMed Arduino PG, Tirone F, Schiorlin E, Esposito M. Single preoperative dose of prophylactic amoxicillin versus a 2-day postoperative course in dental implant surgery: a two-centre randomised controlled trial. Eur J Oral Implantol. 2015;8:143–9.PubMed
80.
go back to reference Cachovan G, Boger RH, Giersdorf I, Hallier O, Streichert T, Haddad M, et al. Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial. Antimicrob Agents Chemother. 2011;55:1142–7. https://doi.org/10.1128/AAC.01267-10.CrossRefPubMed Cachovan G, Boger RH, Giersdorf I, Hallier O, Streichert T, Haddad M, et al. Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial. Antimicrob Agents Chemother. 2011;55:1142–7. https://​doi.​org/​10.​1128/​AAC.​01267-10.CrossRefPubMed
81.
Metadata
Title
A systematic review of latest evidence for antibiotic prophylaxis and therapy in oral and maxillofacial surgery
Authors
Sebastian Blatt
Bilal Al-Nawas
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2019
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01303-8

Other articles of this Issue 4/2019

Infection 4/2019 Go to the issue